These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 24557918)
1. In utero delivery of oligodeoxynucleotides for gene correction. Cai L; Koppanati BM; Bertoni C; Clemens PR Methods Mol Biol; 2014; 1114():399-411. PubMed ID: 24557918 [TBL] [Abstract][Full Text] [Related]
2. Site-directed gene repair of the dystrophin gene mediated by PNA-ssODNs. Kayali R; Bury F; Ballard M; Bertoni C Hum Mol Genet; 2010 Aug; 19(16):3266-81. PubMed ID: 20542988 [TBL] [Abstract][Full Text] [Related]
3. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy. Nik-Ahd F; Bertoni C Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122 [TBL] [Abstract][Full Text] [Related]
4. Methods for the assessment of ssODN-mediated gene correction frequencies in muscle cells. Bertoni C Methods Mol Biol; 2014; 1114():59-83. PubMed ID: 24557897 [TBL] [Abstract][Full Text] [Related]
5. Full-length dystrophin gene transfer to the mdx mouse in utero. Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052 [TBL] [Abstract][Full Text] [Related]
6. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle. Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713 [TBL] [Abstract][Full Text] [Related]
8. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle. Kapsa RM; Wong SH; Quigley AF Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218 [TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle. Takeshima Y; Yagi M; Wada H; Matsuo M Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206 [TBL] [Abstract][Full Text] [Related]
10. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero. Bilbao R; Reay DP; Wu E; Zheng H; Biermann V; Kochanek S; Clemens PR Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668 [TBL] [Abstract][Full Text] [Related]
11. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Liang KW; Nishikawa M; Liu F; Sun B; Ye Q; Huang L Gene Ther; 2004 Jun; 11(11):901-8. PubMed ID: 14985786 [TBL] [Abstract][Full Text] [Related]
19. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [TBL] [Abstract][Full Text] [Related]
20. Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene. Koppanati BM; Li J; Reay DP; Wang B; Daood M; Zheng H; Xiao X; Watchko JF; Clemens PR Gene Ther; 2010 Nov; 17(11):1355-62. PubMed ID: 20535217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]